Skip to main content

Table 2 Quantitative results from [18F]RO948 and [18F]PI-2620 SUVR in Braak regions

From: Head-to-head comparison of tau PET tracers [18F]PI-2620 and [18F]RO948 in non-demented individuals with brain amyloid deposition: the TAU-PET FACEHBI cohort

ROI

[18F]RO948 SUVR

[18F]PI-2620 SUVR

SUVR difference

R[95% CI]

Slope [95% CI]

Intercept [95% CI]

Braak I

1.34 ± 0.26

1.42 ± 0.24

−0.079 ± 0.143

0.69 [0.47; 0.83]

0.90 [0.64; 1.48]

0.21 [−0.50; 0.55]

Braak II

1.01 ± 0.18

1.00 ± 0.18

0.004 ± 0.104

0.70 [0.48; 0.83]

1.00 [0.69; 1.42]

−0.01 [−0.39; 0.30]

Braak III

1.15 ± 0.20

1.09 ± 0.20

0.062 ± 0.093

0.80 [0.51; 0.87]

1.04 [0.70; 1.40]

−0.11 [−0.51; 0.27]

Braak IV

1.27 ± 0.21

1.15 ± 0.23

0.120 ± 0.104

0.79 [0.18; 0.88]

1.11 [0.65; 1.60]

−0.26 [−0.88; 0.29]

Braak V

1.06 ± 0.15

0.94 ± 0.18

0.126 ± 0.103

0.67 [0.01; 0.78]

1.22 [0.70; 2.03]

−0.36 [−1.23; 0.18]

Braak VI

1.01 ± 0.13

0.88 ± 0.15

0.126 ± 0.091

0.65 [0.20; 0.77]

1.19 [0.69; 2.07]

−0.32 [−1.22; 0.17]

  1. Pearson R square, slope, and intercept are tabulated for every Braak region. Slope and intercept were calculated using a total least square approach, with [18F]RO948 as independent variable (i.e., SUVR_PI2620 = slope * SUVR_RO948 + intercept). Abbreviations: CI confidence interval, ROI region of interest, SUVR standardized uptake value ratio